Table 2.
Demographic data.
| TBI | Age | Sex | GCS | 28-Day Mortality | GOSE 6-Months Outcome | RQ | Mean GOSE |
|---|---|---|---|---|---|---|---|
| Total (n = 144) | 48 (IQR: 32–59) | 26 female 118 male | 5 (IQR: 3–6) | 42 patients (29.17%) | Death | 2 | 5.1 ± 2.1 |
| VS | 8 | ||||||
| SD- | 10 | ||||||
| SD+ | 7 | ||||||
| MD- | 11 | ||||||
| MD+ | 7 | ||||||
| GR- | 13 | ||||||
| GR+ | 10 | ||||||
| DAI (n = 29) | 50 (IQR: 35–57) | 4 female 25 male | 4.6 ± 1.1 | 13 patients (44.83%) | Death | 2 | 5.4 ± 1.98 |
| VS | 2 | ||||||
| SD- | 0 | ||||||
| SD+ | 0 | ||||||
| MD- | 2 | ||||||
| MD+ | 2 | ||||||
| GR- | 4 | ||||||
| GR+ | 0 | ||||||
| CE (n = 34) | 44 (IQR: 32–57) | 7 female 27 male | 5.3 ± 1.96 | 6 patients (17.65%) | Death | 0 | 4.9 ± 1.79 |
| VS | 2 | ||||||
| SD- | 4 | ||||||
| SD+ | 0 | ||||||
| MD- | 7 | ||||||
| MD+ | 2 | ||||||
| GR- | 4 | ||||||
| GR+ | 1 | ||||||
| ICH (n = 19) | 54 (IQR: 43–59) | 2 female 17 male | 4.3 ± 1.5 | 10 patients (52.63%) | Death | 0 | 3.7 ± 1.3 |
| VS | 2 | ||||||
| SD- | 3 | ||||||
| SD+ | 2 | ||||||
| MD- | 1 | ||||||
| MD+ | 1 | ||||||
| GR- | 0 | ||||||
| GR+ | 0 | ||||||
| S-EH/SAH (n = 62) | 44 (IQR: 29–60) | 10 female 52 male | 5.3 ± 1.8 | 13 patients (20.97%) | Death | 0 | 5.8 ± 2.14 |
| VS | 2 | ||||||
| SD- | 3 | ||||||
| SD+ | 6 | ||||||
| MD- | 1 | ||||||
| MD+ | 2 | ||||||
| GR- | 5 | ||||||
| GR+ | 9 |
RQ—respondents to questionnaire, DAI—diffuse axonal injury, CE—cerebral edema, ICH—intracerebral hemorrhage, S-EH/SAH—subarachnoid hemorrhage, epidural and/or subdural hematoma, GCS—Glasgow Coma Scale, GOSE—Extended Glasgow Outcome Score.